CoChat

Target Gene Activation of the Wnt Signaling Pathway in Nuclear β‐Catenin Accumulating Cells of Adamantinomatous Craniopharyngiomas

Open access
Hölsken, Annett, Kreutzer, Jürgen, Hofmann, Bernd M., Hans, Volkmar, Oppel, Falk, Buchfelder, Michael, Fahlbusch, Rudolf, Blümcke, Ingmar, Buslei, Rolf · 2009 · Brain Pathology
Cited by 78

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Activating β‐catenin (CTNNB1) mutations can be identified in the majority of adamantinomatous craniopharyngiomas (adaCP), suggesting an aberrant Wnt signaling pathway in this histopathologically peculiar tumor entity. However, there is no proven evidence that nuclear translocation of β‐catenin is associated with CTNNB1 mutations and target gene activation. We performed a laser‐microdissection‐based study comparing β‐catenin accumulating vs. non‐accumulating tumor cells. Mutational analysis and gene expression profiling using real‐time polymerase chain reaction were conducted in adamantinomatous and papillary tumor specimens. Target gene activation, that is, over‐expression of Axin2 could be detected in adaCP, especially in tumor cells with nuclear β‐catenin accumulation. In addition, increased expression of BMP4 was identified in the accumulating cell population, which supports the hypothesis of an oral ectodermal origin. Interestingly, accumulating and non‐accumulating tumor cell populations carried CTNNB1 mutations within exon 3. We extended the analysis, therefore, towards genetic regions encoding for membrane linkage and active/passive nuclear transport mechanisms (exon 4 and exon 8–13), but could not detect any alteration. This is the first report demonstrating an association between nuclear β‐catenin accumulation and target gene activation in adaCP. The results confirm the Wnt signaling pathway as molecular basis of the distinct and challenging clinical and morphological phenotype of adaCP.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1750-3639.2008.00180.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 78

Metadata

Authors
Hölsken, A., Kreutzer, J., Hofmann, B. M., Hans, V., Oppel, F., Buchfelder, M., Fahlbusch, R., Blümcke, I., & Buslei, R.
Venue
Brain Pathology
Publisher
Wiley
Published
2009-06-10
Volume
19
Issue
3
Pages
357-364
ISSN
  • 1015-6305 (ISSN-L)
  • 1750-3639
OpenAlex
W1975047151
Cited by
78
References
1
FWCI
1.24
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Target Gene Activation of the Wnt Signaling Pathway in Nuclear β‐Catenin Accumulating Cells of Adamantinomatous Craniopharyngiomas. https://app.cochat.ai/papers/10.1111/j.1750-3639.2008.00180.x
The paper
Hölsken, A., Kreutzer, J., Hofmann, B. M., Hans, V., Oppel, F., Buchfelder, M., Fahlbusch, R., Blümcke, I., & Buslei, R. (2009). Target Gene Activation of the Wnt Signaling Pathway in Nuclear β‐Catenin Accumulating Cells of Adamantinomatous Craniopharyngiomas. Brain Pathology. https://doi.org/10.1111/j.1750-3639.2008.00180.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.